Company: BIAF
Filing Date: 2025-09-17
Form Type: 8-K
Source: 0001493152-25-013892
Chunk: 1

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-09-17
Form: 8-K
Item: Item 5.03
Chunk 1
---
Item
5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

As
previously reported in a Current Report on Form 8-Kwith the Securities and Exchange Commission
(the “ SEC”), on July 25, 2025, bioAffinity Technologies, Inc. (the “ Company”) held its annual meeting
of stockholders (the “ Annual Meeting”). At the Annual Meeting, the stockholders approved a proposal to amend the Company’s
certificate of incorporation to effect a reverse split of the Company’s outstanding shares of common stock, par value $0.007 (the
“ Common Stock”) at a ratio of one-for two (1:for:2) to one-for-one hundred (1:for:100), with the ratio within such range
to be determined at the discretion of the Company’s board of directors (the “ Board”).

Following
the Annual Meeting, the Board approved a one-for-thirty (1-for-30) reverse split of the Company’s issued and outstanding shares
of Common Stock (the “ Reverse Stock Split”). On September 17, 2025, the Company filed with the Secretary of State of the
State of Delaware a certificate of amendment to its certificate of incorporation (the “ Certificate of Amendment”) to effect
the Reverse Stock Split. The Reverse Stock Split will become effective as of 4:01 p. m. Eastern Time on September 18, 2025, and the Company’s
common stock will begin trading on a split-adjusted basis when the Nasdaq Stock Market opens on September 19, 2025. The Reverse Stock
Split is primarily intended to bring the Company into compliance with Nasdaq’s
minimum bid price requirement.

When
the Reverse Stock Split becomes effective, every thirty (30) shares of the Company’s issued and outstanding Common Stock will be
automatically combined, converted and changed into one (1) share the Company’s Common Stock, without any change in the number of
authorized shares or the par value per share. In addition, a proportionate adjustment will be made to the per share exercise price and
the number of shares issuable upon the exercise of all outstanding stock options, restricted stock units and warrants to purchase shares
of common stock and the number of shares reserved for issuance pursuant to the Company’s equity incentive compensation plans. The
Reverse Stock Split will affect all of our stockholders uniformly and will not affect any stockholder’s percentage ownership interests
in our company, except those stockholders who